3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Dermatologic
1
Breast
1
Conditions
Smoking Cessation
4
Lung Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Squamous Cell Carcinoma of Head and Neck
2
Vaping
1
Uterine Cervical Neoplasms
1
Uterine Cervical Dysplasia
1
Urinary Bladder Neoplasms
1
Tobacco Use Disorder
1
Tobacco Use
1
Stomach Neoplasms
1
Small Cell Lung Carcinoma
1
Recurrence
1
Pancreatic Neoplasms
1
Oropharyngeal Neoplasms
1
Neoplasms
1
Nasopharyngeal Neoplasms
1
Mouth Neoplasms
1
Melanoma
1
Liver Neoplasms
1
Leukemia, Myeloid, Acute
1
Leukemia
1
Laryngeal Neoplasms
1
Kidney Neoplasms
1
Hypopharyngeal Neoplasms
1
Head and Neck Neoplasms
1
Gastrointestinal Neoplasms
1
Esophageal Neoplasms
1
Cigarette Smoking-Related Carcinoma
1
Carcinoma, Renal Cell
1
Interventions
Exercise
112
Surveys and Questionnaires
56
Early Intervention, Educational
49
Standard of Care
46
Methods
46
Magnetic Resonance Spectroscopy
45
Blood Specimen Collection
44
Acupuncture Therapy
44
Educational Status
43
Radiotherapy
36
Mammography
36
Control Groups
31
Therapeutics
29
Counseling
29
Psychiatric Rehabilitation
27
Cyclophosphamide
27
Sentinel Lymph Node Biopsy
25
Biopsy
24
Yoga
20
Mastectomy, Segmental
20
Resistance Training
19
Palliative Care
18
Neoadjuvant Therapy
18
High-Energy Shock Waves
18
Doxorubicin
18
Cognitive Behavioral Therapy
18
Magnetic Resonance Imaging
17
Practice Guidelines as Topic
16
Paclitaxel
16
Trastuzumab
15
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Breast Neoplasms
×
Nicotine Replacement Therapy
×
Clear all
NCT04899492
2024-11-07
RESPIRE
Institut Cancerologie de l'Ouest
Phase NA
Terminated
22 enrolled